Ohio Tequin® Lawyers

Tequin® CLAIMS

Schedule a consultation or ask us a free legal question

What is Tequin?

Tequin is an antibiotic in the class of antibiotics called fluoroquinolones. It is intended for treatment of infections in adults, such as lung, sinus and urinary tract infections, as well as certain sexually transmitted diseases. Last year Tequin had worldwide sales of $150 million, including $100 million in the United States.

Who is the manufacturer?

Bristol-Myers Squibb Company with headquarters in New York City.

What is the problem with this drug?

Tequin has been linked to serious cases of diabetes and other potentially fatal blood sugar abnormalities. According to a Canadian study published in 2006 in the New England Journal of Medicine, Tequin users have a 17 times greater risk of developing serious diabetes and four times greater risk of being hospitalized with low blood sugar complications than patients using other antibiotics. Consumer group Public Citizen says there have been 388 patients with blood-sugar irregularities linked to Tequin since January 1, 2000. Those cases included 20 deaths and 159 hospitalizations.

Is it still on the market?

No. On May 1, 2006, Bristol-Myers Squibb stated that it will cease making and selling Tequin.

Warning for diabetics may apply to anyone taking Tequin.

In early 2006, Bristol Myers Squibb and the FDA added a warning to the drug's label notifying diabetics not to take Tequin. However, the blood-sugar problem can also occur in people without diabetes, and it usually occurs within a few days of taking the drug.

Do I have a case?

If you were hospitalized for high or low blood sugar while taking Tequin, you might have a case. There are also cases for deaths that occurred as a result of blood sugar abnormalities associated with Tequin.